{"version":"1.0","provider_name":"Division of Infectious Diseases","provider_url":"https:\/\/blog.unmc.edu\/infectious-disease","author_name":"Zachary Van Roy","author_url":"https:\/\/blog.unmc.edu\/infectious-disease\/author\/c7635bfd99248a2cdef8249ef7bfbef4\/","title":"Research Digest: Antimicrobial Advances (Part 2) - Division of Infectious Diseases","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"OAn4ZRXDam\"><a href=\"https:\/\/blog.unmc.edu\/infectious-disease\/2023\/10\/26\/research-digest-antimicrobial-advances-part-2\/\">Research Digest: Antimicrobial Advances (Part 2)<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blog.unmc.edu\/infectious-disease\/2023\/10\/26\/research-digest-antimicrobial-advances-part-2\/embed\/#?secret=OAn4ZRXDam\" width=\"600\" height=\"338\" title=\"&#8220;Research Digest: Antimicrobial Advances (Part 2)&#8221; &#8212; Division of Infectious Diseases\" data-secret=\"OAn4ZRXDam\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blog.unmc.edu\/infectious-disease\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Research Digest is a periodic installment that recognizes the world-class clinical research performed right here at UNMC ID. Last time, we reviewed two articles covering advances in antibiotic and antimicrobial medications. This week, we feature three more articles from UNMC exploring the pharmaceutical treatment of different infectious diseases with wide-reaching implications. As always, be sure to check out the linked full articles for more details","thumbnail_url":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-content\/uploads\/sites\/54\/2020\/01\/scarsiindiv.jpg"}